Biosimilars Forum Supports Inclusion of Biosimilars in the Medicare Coverage Gap Discount Program

Washington, D.C., February 12, 2018 – The Biosimilars Forum supports inclusion of biosimilars in the Medicare Coverage Gap Discount Program (CGDP), or donut hole, as part of the 2018 Budget Agreement. The policy requires biosimilar manufacturers to pay the discounts paid by their brand competitors, allowing them to participate on a level playing field, and drive savings to the millions of Medicare beneficiaries who receive coverage through the Part D program. Further, the policy encourages biosimilar uptake that will ultimately yield lower costs and increased access for patients.

About the Biosimilars Forum

The Biosimilars Forum is a nonprofit organization whose mission is to advance biosimilars in the United States with the intent of expanding access and availability of biological medicines, and improving health care. The founding members of the Biosimilars Forum represent the majority of companies with the most significant U.S. biosimilars development portfolios.

To learn more about biosimilars, the Forum, and how to get involved, visit, @USbiosimilars, or Facebook/USBiosimilars to follow related conversations and join the dialogue.

Aimee Steel Lubin